Ginkgo Bioworks Holdings, Inc. (DNA) — Stock Score Summary

Ginkgo Bioworks Holdings, Inc. (DNA) has a MoatMap StockRank of 19/100 based on Quality (27/100), Value (44/100), and Momentum (34/100) factor scores. The current signal is STRONG SELL. Ginkgo Bioworks has suffered from massive cash burn, a broken business model, and a lack of clear path to profitability (Q: 27). It fails the Terry Smith filter of avoiding speculative, non-profitable tech platforms.

Ginkgo Bioworks Holdings, Inc. operates a horizontal platform for cell programming, providing research and development services to customers across agriculture, pharmaceuticals, and industrial chemicals. The company leverages its proprietary 'Foundry' and 'Codebase' to reduce the cost and time of biological design, benefiting from scale economies as more programs are added. It is a leading, platform-based synthetic biology pioneer.

Key Financial Metrics

Price$8.73
Market Cap$618M
P/E (Forward)-2.82
Price/Book1.26
Return on Equity-56.0%
Return on Invested Capital-30.6%
Debt/Equity92.68
Gross Margin69.6%
Operating Margin-366.5%
Revenue Growth-49.1%
Free Cash Flow$-78M

Ginkgo Bioworks Holdings, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Ginkgo Bioworks Holdings, Inc.’s (DNA) StockRank?
MoatMap’s StockRank for Ginkgo Bioworks Holdings, Inc. (DNA) is 19/100, with a Strong Sell signal. It is a composite of Quality (27), Value (44), and Momentum (34) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ginkgo Bioworks Holdings, Inc. have an economic moat?
Ginkgo Bioworks Holdings, Inc. (DNA) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ginkgo Bioworks Holdings, Inc. a buy, hold, or sell?
MoatMap’s current signal for Ginkgo Bioworks Holdings, Inc. (DNA) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ginkgo Bioworks Holdings, Inc. in?
Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksDNA deep dive reportAI ChampionsHow we score stocksSense-check another stock